43 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
2 May 22
Regulation FD Disclosure
4:00pm
Code - derived Decoy Receptors / Hemofiltartion System / Novel Therapeutic Targets - Precision Companion Diagnostics Corporate Overview … Innovative Research, Novel Targets / Delivery, Strong IP Protection cGMP Bioprocessing & Bioproduction Capabitities, QC/QA, Accreditation (FACT, aaBB
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
, greatly enhancing the solubility of designer peptides and proteins, therefore potentially expanding the repertoire of selected therapeutic targets … of the “cytokine storm” associated with COVID-19 and cellular immunotherapy delivery, as well as broadening the range of therapeutic targets addressable
8-K
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
therapeutic targets against cancers and other diseases. The resulting soluble, antibody-like cytokine/chemokine decoy receptors derived using the QTY … immunotherapy delivery, as well as broadening the range of therapeutic targets addressable by CAR T-cell therapies.
Item 9.01. Financial Statements
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am
receptors found on the surface of immune cells and cancer cells that function in cell signaling and are important drug targets. This system also … provides Avalon with an efficient tool to screen and optimize potential therapeutic targets.
Avalon has co-developed and jointly filed a patent with BOKU
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
31 Jan 19
Other Events
3:04pm
, non-invasive biomarkers in detecting and monitoring tumors as well as therapeutic targets,” commented by Yu Zhou, M.D., Ph.D., Co-CEO of Genexosome
8-K
EX-99.1
kabltlcyjcmgco9h2w
8 Nov 22
Entry into a Material Definitive Agreement
9:15am
S-8
zw3ukohp8d1xxpn7
8 Dec 20
Registration of securities for employees
4:30pm
424B3
9cb3n3
29 Jun 23
Prospectus supplement
4:31pm